- Home
- TOP vs IMRX Comparison
TOP vs IMRX Comparison
Compare TOP & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- IMRX
- Stock Information
- Founded
- TOP 2015
- IMRX 2008
- Country
- TOP Hong Kong
- IMRX United States
- Employees
- TOP N/A
- IMRX N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- TOP Finance
- IMRX Health Care
- Exchange
- TOP Nasdaq
- IMRX Nasdaq
- Market Cap
- TOP 57.8M
- IMRX 62.7M
- IPO Year
- TOP 2022
- IMRX 2021
- Fundamental
- Price
- TOP $1.47
- IMRX $2.02
- Analyst Decision
- TOP
- IMRX Buy
- Analyst Count
- TOP 0
- IMRX 7
- Target Price
- TOP N/A
- IMRX $12.80
- AVG Volume (30 Days)
- TOP 195.0K
- IMRX 4.9M
- Earning Date
- TOP 01-29-2025
- IMRX 02-28-2025
- Dividend Yield
- TOP N/A
- IMRX N/A
- EPS Growth
- TOP N/A
- IMRX N/A
- EPS
- TOP 0.03
- IMRX N/A
- Revenue
- TOP $8,037,105.00
- IMRX N/A
- Revenue This Year
- TOP N/A
- IMRX N/A
- Revenue Next Year
- TOP N/A
- IMRX N/A
- P/E Ratio
- TOP $45.12
- IMRX N/A
- Revenue Growth
- TOP N/A
- IMRX N/A
- 52 Week Low
- TOP $1.25
- IMRX $1.00
- 52 Week High
- TOP $7.77
- IMRX $7.68
- Technical
- Relative Strength Index (RSI)
- TOP 47.79
- IMRX 47.82
- Support Level
- TOP $1.35
- IMRX $1.84
- Resistance Level
- TOP $1.50
- IMRX $3.80
- Average True Range (ATR)
- TOP 0.12
- IMRX 0.29
- MACD
- TOP 0.00
- IMRX -0.03
- Stochastic Oscillator
- TOP 42.50
- IMRX 9.18
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.